These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 32245796)

  • 1. Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Is Associated with Indigenous American Ancestry in Latin American Women.
    Marker KM; Zavala VA; Vidaurre T; Lott PC; Vásquez JN; Casavilca-Zambrano S; Calderón M; Abugattas JE; Gómez HL; Fuentes HA; Picoaga RL; Cotrina JM; Neciosup SP; Castañeda CA; Morante Z; Valencia F; Torres J; Echeverry M; Bohórquez ME; Polanco-Echeverry G; Estrada-Florez AP; Serrano-Gómez SJ; Carmona-Valencia JA; Alvarado-Cabrero I; Sanabria-Salas MC; Velez A; Donado J; Song S; Cherry D; Tamayo LI; Huntsman S; Hu D; Ruiz-Cordero R; Balassanian R; Ziv E; Zabaleta J; Carvajal-Carmona L; Fejerman L;
    Cancer Res; 2020 May; 80(9):1893-1901. PubMed ID: 32245796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between Ancestry-Specific 6q25 Variants and Breast Cancer Subtypes in Peruvian Women.
    Zavala VA; Casavilca-Zambrano S; Navarro-Vásquez J; Castañeda CA; Valencia G; Morante Z; Calderón M; Abugattas JE; Gómez H; Fuentes HA; Liendo-Picoaga R; Cotrina JM; Monge C; Neciosup SP; Huntsman S; Hu D; Sánchez SE; Williams MA; Núñez-Marrero A; Godoy L; Hechmer A; Olshen AB; Dutil J; Ziv E; Zabaleta J; Gelaye B; Vásquez J; Gálvez-Nino M; Enriquez-Vera D; Vidaurre T; Fejerman L
    Cancer Epidemiol Biomarkers Prev; 2022 Aug; 31(8):1602-1609. PubMed ID: 35654312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer subtype and clinical characteristics in women from Peru.
    Zavala VA; Casavilca-Zambrano S; Navarro-Vásquez J; Tamayo LI; Castañeda CA; Valencia G; Morante Z; Calderón M; Abugattas JE; Gómez HL; Fuentes HA; Liendo-Picoaga R; Cotrina JM; Neciosup SP; Roque K; Vásquez J; Mas L; Gálvez-Nino M; Fejerman L; Vidaurre T
    Front Oncol; 2023; 13():938042. PubMed ID: 36925912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-specific incidence of breast cancer subtypes: understanding the black-white crossover.
    Clarke CA; Keegan TH; Yang J; Press DJ; Kurian AW; Patel AH; Lacey JV
    J Natl Cancer Inst; 2012 Jul; 104(14):1094-101. PubMed ID: 22773826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial disparities in breast cancer diagnosis and treatment by hormone receptor and HER2 status.
    Chen L; Li CI
    Cancer Epidemiol Biomarkers Prev; 2015 Nov; 24(11):1666-72. PubMed ID: 26464428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Racial comparison of receptor-defined breast cancer in Southern African women: subtype prevalence and age-incidence analysis of nationwide cancer registry data.
    Dickens C; Duarte R; Zietsman A; Cubasch H; Kellett P; Schüz J; Kielkowski D; McCormack V
    Cancer Epidemiol Biomarkers Prev; 2014 Nov; 23(11):2311-21. PubMed ID: 25143359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translational Epidemiology: An Integrative Approach to Determine the Interplay Between Genetic Ancestry and Neighborhood Socioeconomic Status on Triple Negative Breast Cancer.
    Goel N; Yadegarynia S; Kwon D; Kesmodel SB; Harbour JW; Kobetz E; Merchant N; Rodriguez DA
    Ann Surg; 2022 Sep; 276(3):430-440. PubMed ID: 35758508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State.
    Kohler BA; Sherman RL; Howlader N; Jemal A; Ryerson AB; Henry KA; Boscoe FP; Cronin KA; Lake A; Noone AM; Henley SJ; Eheman CR; Anderson RN; Penberthy L
    J Natl Cancer Inst; 2015 Jun; 107(6):djv048. PubMed ID: 25825511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reproductive characteristics, menopausal status, race and ethnicity, and risk of breast cancer subtypes defined by ER, PR and HER2 status: the Breast Cancer Etiology in Minorities study.
    John EM; Koo J; Phipps AI; Longacre TA; Kurian AW; Ingles SA; Wu AH; Hines LM
    Breast Cancer Res; 2024 May; 26(1):88. PubMed ID: 38822357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced stages and poorly differentiated grade are associated with an increased risk of HER2/neu positive breast carcinoma only in White women: findings from a prospective cohort study of African-American and White-American women.
    Stark A; Kapke A; Schultz D; Brown R; Linden M; Raju U
    Breast Cancer Res Treat; 2008 Feb; 107(3):405-14. PubMed ID: 17431759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status.
    Howlader N; Altekruse SF; Li CI; Chen VW; Clarke CA; Ries LA; Cronin KA
    J Natl Cancer Inst; 2014 Apr; 106(5):. PubMed ID: 24777111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial Differences in the Use and Outcome of Neoadjuvant Chemotherapy for Breast Cancer: Results From the National Cancer Data Base.
    Killelea BK; Yang VQ; Wang SY; Hayse B; Mougalian S; Horowitz NR; Chagpar AB; Pusztai L; Lannin DR
    J Clin Oncol; 2015 Dec; 33(36):4267-76. PubMed ID: 26598753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lifetime risks of specific breast cancer subtypes among women in four racial/ethnic groups.
    Kurian AW; Fish K; Shema SJ; Clarke CA
    Breast Cancer Res; 2010; 12(6):R99. PubMed ID: 21092082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic ancestry and risk factors for breast cancer among Latinas in the San Francisco Bay Area.
    Ziv E; John EM; Choudhry S; Kho J; Lorizio W; Perez-Stable EJ; Burchard EG
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1878-85. PubMed ID: 17035394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic ancestry modifies the association between genetic risk variants and breast cancer risk among Hispanic and non-Hispanic white women.
    Fejerman L; Stern MC; Ziv E; John EM; Torres-Mejia G; Hines LM; Wolff R; Wang W; Baumgartner KB; Giuliano AR; Slattery ML
    Carcinogenesis; 2013 Aug; 34(8):1787-93. PubMed ID: 23563089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mortality risk of black women and white women with invasive breast cancer by hormone receptors, HER2, and p53 status.
    Ma H; Lu Y; Malone KE; Marchbanks PA; Deapen DM; Spirtas R; Burkman RT; Strom BL; McDonald JA; Folger SG; Simon MS; Sullivan-Halley J; Press MF; Bernstein L
    BMC Cancer; 2013 May; 13():225. PubMed ID: 23642215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA.
    Lund MJ; Trivers KF; Porter PL; Coates RJ; Leyland-Jones B; Brawley OW; Flagg EW; O'Regan RM; Gabram SG; Eley JW
    Breast Cancer Res Treat; 2009 Jan; 113(2):357-70. PubMed ID: 18324472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial Differences in PAM50 Subtypes in the Carolina Breast Cancer Study.
    Troester MA; Sun X; Allott EH; Geradts J; Cohen SM; Tse CK; Kirk EL; Thorne LB; Mathews M; Li Y; Hu Z; Robinson WR; Hoadley KA; Olopade OI; Reeder-Hayes KE; Earp HS; Olshan AF; Carey LA; Perou CM
    J Natl Cancer Inst; 2018 Feb; 110(2):176-82. PubMed ID: 28859290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic features of breast cancer differ between women in the Democratic Republic of Congo and Belgium.
    Luyeye Mvila G; Batalansi D; Praet M; Marchal G; Laenen A; Christiaens MR; Brouckaert O; Ali-Risasi C; Neven P; Van Ongeval C
    Breast; 2015 Oct; 24(5):642-8. PubMed ID: 26279132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study.
    Carey LA; Perou CM; Livasy CA; Dressler LG; Cowan D; Conway K; Karaca G; Troester MA; Tse CK; Edmiston S; Deming SL; Geradts J; Cheang MC; Nielsen TO; Moorman PG; Earp HS; Millikan RC
    JAMA; 2006 Jun; 295(21):2492-502. PubMed ID: 16757721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.